Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2025Nephrology Dialysis Transplantation

Targeted Therapeutic Options Based on the Pathogenesis of IgA Nephropathy

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSara Dal BoASAo SunWYWeiguang Yang

Discussion

Loading...

Member takes

Overview

Review highlights new treatment strategies for IgA nephropathy, which may improve chronic kidney disease outcomes.

Key Points

  • Chronic kidney disease is common among patients with iga nephropathy, leading to worsening prognosis and healthcare costs.
  • Recent advancements in treatment can target immune complexes in mesangial cells, altering disease outcomes significantly.
  • Current therapies focus on managing symptoms while newer drugs aim at the disease's underlying pathogenesis and inflammatory responses.
  • A comprehensive approach may help mitigate glomerular inflammatory processes and promote kidney health in affected individuals.

Cite This Study

Bo et al. (2025) studied this question.

synapsesocial.com/papers/68af3e42cf1dd9ea359eb439https://doi.org/10.1093/ndt/gfaf167
View Full Paper
Ask AI
Bookmark
Share